IBIO

Conviction 14HealthcareScan · Thu, Jun 25, 2026

IBIO$1.60-1.23%

ResistanceSupportVol 14

Vol MA14 866.54K

Mar 26Apr 14May 1May 19Jun 8Jun 25

iBio, Inc.PHARMACEUTICAL PREPARATIONSwww.ibioinc.com ↗

Price1.60

Change-1.23%

Gap+0.93%

Rel volume1.05×

Avg volume822.15K

Avg $ vol1.42M

SMA 201.73

SMA 501.73

SMA 2001.74

Price vs 50-7.71%

Price vs 200-8.12%

MA stackbearish

50/200 crossdeath · 0d

Supertrendup · 1.50

RSI (14)43

MACD hist-0.01

MACD cross—

Stoch %K / %D20 / 24

ADX (14)12

+DI / −DI18 / 25

RSI divergence—

MACD divergence—

ATR %+7.80%

ADR %7.35%

52w high3.07

52w low0.5731

From 52w high-47.88%

Above 52w low+179.18%

New 52w highNo

SqueezeOff

Bollinger width26.07%

%B0.21

Donchian pos19.67%

Donchian high2.09

Donchian low1.48

AVWAP (52w high)2.34

vs AVWAP high-31.53%

AVWAP (52w low)1.82

vs AVWAP low-12.28%

OBV trendDown

Chaikin MF (20)-0.23

Today vs 20d1.05×

Avg vol (14d)866.54K

Avg vol (20d)822.15K

Avg $ vol (20d)1.42M

Market cap79.49M

RS 3m (vs SPY)-34.37%

RS 6m (vs SPY)-25.92%

RS line new highNo

Trend template3/8

Technical rank20.6

1 week+0.00%

1 month-12.09%

3 months-26.61%

6 months-20.40%

1 year+113.90%

YTD-20.79%

P/E-4.33

P/B1.03

P/S198.71

P/FCF-5.19

EPS-1.75

Div yield—

ROE-23.70%

ROA-21.41%

Debt/Eq—

Current11.88

EV/EBITDA-1.73

Gross margin541.75%

Net margin—

Rev growth77.78%

EPS growth26.22%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value31.85M

Revenue0

Net income-7.73M

Gross profit1.9M

Free cash flow-15.32M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out49.68M

Employees20

ListedTue, Aug 19, 2008

Free float31.53M

Float %91.3%

Short interest3.76M

Days to cover4.8d

Short volume55.1%

Squeeze score59 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction14 / 100

Pattern quality—

Tech rank20.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance2.05

Support1.43

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IBIO

All disclosures →

No recent disclosed trades by Congress in IBIO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IBIO · 1 buy

Insider	Side	Shares	Value	Traded	Filed
Stoner Elizabeth Director · Stock Option (right to buy) · 2026-05-18	Grant	60K	$0	2026-05-18	2026-05-19

SEC filings

EDGAR filings in IBIO

EDGAR →

No recent SEC filings on file for IBIO.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.